 |
 |

Brain Serotonin2 Receptors in Major Depression
A Positron Emission Tomography Study
Lakshmi N. Yatham, MBBS;
Peter F. Liddle, PhD, MBBS;
I-Shin Shiah, MD;
Gayle Scarrow, BA;
Raymond W. Lam, MD;
Michael J. Adam, PhD;
Athanasios P. Zis, MD;
Thomas J. Ruth, PhD
Arch Gen Psychiatry. 2000;57:850-858.
Background Postmortem and brain imaging studies that measured brain serotinin2 (5-HT2) receptors in major depression reported an increase, decrease, and no change compared with controls. In this study, we assessed brain 5-HT2 receptors in 20 depressed patients (mean ± SD age, 40.1 ± 9.5 years; range, 22-60 years) and 20 healthy controls similar in age (37.2 ± 12.6 years; range, 19-59 years) using positron emission tomography and setoperone labeled with fluorine 18 ([18F]setoperone).
Methods Patients with DSM-IV major depression and healthy controls underwent scanning with [18F]setoperone. All study subjects were drug free for at least 2 weeks. The 5-HT2 binding images were created using region-to-cerebellum ratios. The differences in 5-HT2 receptor binding potential between the two groups were determined with statistical parametric mapping software and region of interest analysis.
Results There was a significant negative correlation between 5-HT2 receptor binding potential and age in both patients and controls, and the magnitude of this correlation was similar in both groups. Both statistical parametric mapping and region of interest analyses showed that, compared with healthy controls, depressed patients had significantly lower 5-HT2 receptor binding potential in frontal, temporal, parietal, and occipital cortical regions. Statistical parametric mapping analysis showed that the mean decrease in 5-HT2 receptor binding potential for the entire cluster in these regions was 22%, and it ranged from 22% to 27% for local maxima within the clusters of significant voxels.
Conclusion This study suggests that brain 5-HT2 receptors are decreased in patients with major depression.
From the Division of Mood Disorders (Drs Yatham, Shiah, Lam, and Zis and Ms Scarrow), Division of Schizophrenia, Department of Psychiatry (Dr Liddle), and TRIUMF Positron Emission Tomography Program (Drs Adam and Ruth), The University of British Columbia, Vancouver; and Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (Dr Shiah).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Medial Prefrontal Cortex 5-HT2A Density Is Correlated with Amygdala Reactivity, Response Habituation, and Functional Coupling
Fisher et al.
Cereb Cortex 2009;19:2499-2507.
ABSTRACT
| FULL TEXT
Evaluation of the Brain 5-HT2A Receptor Binding Index in Dogs with Anxiety Disorders, Measured with 123I-5I-R91150 and SPECT
Vermeire et al.
JNM 2009;50:284-289.
ABSTRACT
| FULL TEXT
Molecular Neuroimaging: From Conventional to Emerging Techniques
Hammoud et al.
Radiology 2007;245:21-42.
ABSTRACT
| FULL TEXT
Measurement of Brain Regional {alpha}-[11C]Methyl-L-Tryptophan Trapping as a Measure of Serotonin Synthesis in Medication-Free Patients With Major Depression
Rosa-Neto et al.
Arch Gen Psychiatry 2004;61:556-563.
ABSTRACT
| FULL TEXT
Autism and Familial Major Mood Disorder: Are They Related?
DeLong
J. Neuropsychiatry Clin. Neurosi. 2004;16:199-213.
ABSTRACT
| FULL TEXT
Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
Schins et al.
Psychosom. Med. 2003;65:729-737.
ABSTRACT
| FULL TEXT
Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm
Meyer et al.
Am. J. Psychiatry 2003;160:90-99.
ABSTRACT
| FULL TEXT
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression
HICKS et al.
Br. J. Psychiatry 2002;180:528-535.
ABSTRACT
| FULL TEXT
State and trait abnormalities in serotonin function in major depression
BHAGWAGAR et al.
Br. J. Psychiatry 2002;180:24-28.
ABSTRACT
| FULL TEXT
|